These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12393362)

  • 1. Haemodynamic effects of an angiotensin-converting enzyme inhibitor and angiotensin receptor antagonist during hypovolaemia in the anaesthetized pig.
    Ryckwaert F; Colson P; André E; Perrigault PF; Guillon G; Barberis C
    Br J Anaesth; 2002 Oct; 89(4):599-604. PubMed ID: 12393362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: I. Effects on left ventricular performance and neurohormonal systems.
    Spinale FG; de Gasparo M; Whitebread S; Hebbar L; Clair MJ; Melton DM; Krombach RS; Mukherjee R; Iannini JP; O SJ
    Circulation; 1997 Oct; 96(7):2385-96. PubMed ID: 9337215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypovolaemia-induced vasodilatation during angiotensin AT1 receptor blockade: role of the AT2 receptor.
    Ryckwaert F; Colson PH
    Pharmacol Res; 2005 Jan; 51(1):37-40. PubMed ID: 15519533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effects of angiotensin converting enzyme inhibition and angiotensin II receptor antagonism in conscious pigs with congestive heart failure.
    Shen YT; Wiedmann RT; Greenland BD; Lynch JJ; Grossman W
    Cardiovasc Res; 1998 Aug; 39(2):413-22. PubMed ID: 9798526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns.
    Krombach RS; Clair MJ; Hendrick JW; Houck WV; Zellner JL; Kribbs SB; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
    Cardiovasc Res; 1998 Jun; 38(3):631-45. PubMed ID: 9747431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between angiotensin receptor antagonism and converting enzyme inhibition in heart failure. Differential acute effects according to the renin-angiotensin system activation.
    Su J; Barbe F; Houël R; Guyene TT; Crozatier B; Hittinger L
    Basic Res Cardiol; 1999 Apr; 94(2):128-35. PubMed ID: 10326661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: II. Effects on myocyte contractile processes.
    Spinale FG; Mukherjee R; Iannini JP; Whitebread S; Hebbar L; Clair MJ; Melton DM; Cox MH; Thomas PB; de Gasparo M
    Circulation; 1997 Oct; 96(7):2397-406. PubMed ID: 9337216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AT1 angiotensin II receptor inhibition in pacing-induced heart failure: effects on left ventricular performance and regional blood flow patterns.
    Clair MJ; Krombach RS; Hendrick JW; Houck WV; Hebbar L; Kribbs SB; Rios G; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
    J Card Fail; 1998 Dec; 4(4):311-23. PubMed ID: 9924853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of prolonged blockade of the renin angiotensin system on striated muscle microcirculation of spontaneously hypertensive rats.
    Scheidegger KJ; Wood JM; van Essen H; Struijker-Boudier HA
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1276-81. PubMed ID: 8819512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II type 1 receptor blockers.
    Burnier M
    Circulation; 2001 Feb; 103(6):904-12. PubMed ID: 11171802
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 5th communication: hemodynamic effects of valsartan in dog heart failure models.
    Yamamoto S; Hayashi N; Kometani M; Nakao K
    Arzneimittelforschung; 1997 May; 47(5):630-4. PubMed ID: 9205777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular hypertrophy and albumin permeability in a rat model combining hypertension and diabetes mellitus. Effects of calcium antagonism, angiotensin converting enzyme inhibition, and angiotensin II-AT1-receptor blockade.
    Hulthén UL; Cao Z; Rumble JR; Cooper ME; Johnston CI
    Am J Hypertens; 1996 Sep; 9(9):895-901. PubMed ID: 8879346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valsartan in heart failure patients previously untreated with an ACE inhibitor.
    Mazayev VP; Fomina IG; Kazakov EN; Sulimov VA; Zvereva TV; Lyusov VA; Orlov VA; Olbinskaya LI; Bolshakova TD; Sullivan J; Spormann DO
    Int J Cardiol; 1998 Aug; 65(3):239-46. PubMed ID: 9740480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual inhibition of the renin system by aliskiren and valsartan.
    Birkenhäger WH; Staessen JA
    Lancet; 2007 Jul; 370(9583):195-196. PubMed ID: 17658374
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of chronic treatment with losartan and enalaprilat on [3H]-norepinephrine release from isolated atria of Wistar-Kyoto and spontaneously hypertensive rats.
    Foucart S; Patrick SK; Oster L; de Champlain J
    Am J Hypertens; 1996 Jan; 9(1):61-9. PubMed ID: 8834708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the role of the renin-angiotensin system in cardiac contractility utilizing the renin inhibitor remikiren.
    van Kats JP; Sassen LM; Danser AH; Polak MP; Soei LK; Derkx FH; Schalekamp MA; Verdouw PD
    Br J Pharmacol; 1996 Mar; 117(5):891-901. PubMed ID: 8851507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved glucose metabolism following blockade of angiotensin converting enzyme but not angiotensin AT1 receptors.
    Chow L; De Gasparo M; Levens N
    Eur J Pharmacol; 1995 Aug; 282(1-3):77-86. PubMed ID: 7498292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Angiotensin II receptor blockers: current status and future prospects].
    Corvol P; Plouin PF
    Drugs; 2002; 62 Spec No 1():53-64. PubMed ID: 12036389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favourable effects on arterial wave reflection and pulse pressure amplification of adding angiotensin II receptor blockade in resistant hypertension.
    Mahmud A; Feely J
    J Hum Hypertens; 2000 Sep; 14(9):541-6. PubMed ID: 10980584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and coronary effects of the angiotensin II receptor antagonist EXP3174 in dogs.
    Richard V; Berdeaux A; Giudicelli JF
    J Cardiovasc Pharmacol; 1993 Jul; 22(1):52-7. PubMed ID: 7690096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.